Published in Blood Weekly, August 28th, 1995
Any member blood center who elects to become party to the agreement agrees to use exclusively HemaSure's LeukoNet Pre-Storage Leukoreduction Filter System. The LeukoNet Filter, which was cleared by the U.S. Food and Drug Administration (FDA) for marketing on June 28, 1995, is designed for use by blood centers for the pre-storage removal of leukocytes (white blood cells) from transfusion blood.
HemaSure is applying its proprietary filtration and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.